allfeeds.ai

 

Clinical Conversations  

Clinical Conversations

Author: Geistlich Biomaterials

Join Geistlich Biomaterials as we delve into the 'hot topics' related to Implant Dentistry from Ridge Preservation to Major Bone Augmentation, and everything in between!
Be a guest on this podcast

Language: en-gb

Genres: Health & Fitness, Medicine

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it


Get all podcast data

Listen Now...

Clinical Conversations - Robert Felkler Yxoss mesh in Major Bone Augmentation
Episode 5
Thursday, 26 August, 2021

We sit down with Dr Robert Felkler, partner and implant dentist at The Eledent Clinic in Sutton to discuss 'The Application of Yxoss CBR - CAD/CAM technology for use in major grafting cases'.Robert qualified from Queen Mary University of London and had an early interest in Oral Surgery, working as a Staff Grade in North Devon District Hospital. He went on to complete an MSc in Dental Implantology at University of Bristol, allowing him to achieve predicable results using the latest Straumann technology. His main area of expertise involves a combination of Cosmetic dentistry and placement of Dental Implants to restore a healthy, beautiful smile. With extensive experience in Smile Makeovers, he uses a combination of techniques, including Invisalign, tooth whitening and gum re-contouring to correct and perfect your smile. Robert receives referrals from local practices for complex treatments, Implants and Oral Surgery, including the removal of impacted wisdom teeth.

 

We also recommend:


Type 1 diabetes - a long-term condition - for iPod/iPhone
The Open University

Fight for Sight - Eye Research Matters
fightforsight

The Visible Voices
Resa E Lewiss

Teman Sejawat IKA.
Ikatan Alumni FK Unisba

PODCAST UVA

Asociación Latinoamericana de Pie Diabético
ALAPID

Pharmacy Near Me
Craig

"Samayac Cultura Ancestral"
Patricia Solval

Parlons-en: vivre avec une maladie chronique
AbbVie Belgium & Luxembourg

ATRÉVETE A APRENDER
CONAMEGE

EBN Podcast
BMJ Group

Excreción renal de los fármacos
Iris Rivas